Shares of St. Jude Medical (STJ) Sees Large Outflow of Money

St. Jude Medical (STJ) : Net money flow in St. Jude Medical (STJ) was negative ($7.36 million) and the inflow of money on uptick was $19.44 million, whereas, the outflow of money on downticks amounted to $26.8 million on Thursday. The traders used every opportunity of price strength in the stock to sell their positions, hence, the total uptick to downtick ratio was 0.73. The block trades show that the large investors, were aggressive sellers in the stock. On the other hand, the total value of block trades done on downticks was $9.58 million. The money flow in block trades was negative ($9.58). St. Jude Medical (STJ) gained $0.72 cent during the day and reached $80.15, a gain of 0.91% over the previous day.


St. Jude Medical (STJ) : The highest short term price target forecast on St. Jude Medical (STJ) is $91 and the lowest target price is $54. A total of 18 equity analysts are currently covering the company. The average price of all the analysts is $73.81 with a standard deviation of $11.55. The stock has recorded a 20-day Moving Average of 3.88% and the 50-Day Moving Average is 5.35%.

St. Jude Medical (NYSE:STJ): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $79.34 and $79.34 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $80.17. The buying momentum continued till the end and the stock did not give up its gains. It closed at $80.15, notching a gain of 0.91% for the day. The total traded volume was 1,983,440 . The stock had closed at $79.43 on the previous day.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.